The global cell and tissue preservation market size is expected to reach around US$ 9.54 billion by 2030 from US$ 3.56 billion in 2021 and is expected to grow at an impressive double-digit rate of 11.6%% from 2022 to 2030.
The surging demand for the regenerative medicines owing to the rising prevalence of injuries and age related diseases is expected to drive the growth of the cell and tissue preservation market during the forecast period.
The study includes drivers and restraints of this market. The study provides an analysis of the global cell and tissue preservation market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 180+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1642
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global cell and tissue preservation market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global cell and tissue preservation market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global cell and tissue preservation market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for cell and tissue preservation are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global cell and tissue preservation market include:
- Thermo Fisher Scientific, Inc.
- Lonza
- BD
- MerckKGaA
- Cytiva
- Agilent Technologies, Inc.
- Avantor, Inc.
- FUJIFILM Irvine Scientific
- BioLifeSolutions Inc.
- AMSBIO
- Princeton CryoTech
- STEMCELL Technologies Inc.
- LGC SeraCare
- Corning Incorporated
- CellGenix GmbH
Market Segmentation:
By Type
- Cell
- Mammalian Cells
- Others (Microorganisms and Plant Cells)
- Tissue
- Blood
- Bone
- Soft Tissues
- Skin
- Others
By Application
- Therapeutics
- Drug Discovery
- Gene therapy
- IVF treatment
- Cell therapy
- Research & Development
By Product
- Equipment
- Freezers
- Refrigerators
- Storage Systems
- Others
- Software
- Bio-preservation Media
- Home-brew Media
- Pre-formulated Media
By End User
- Biobanks
- Hospitals
By Cell Provider
- CD34+
- CD19+
- MSC
- iPSC
- hESC
- Tumor Cells
- Others
Regional Analysis:
The geographical analysis of the global cell and tissue preservation market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global cell and tissue preservation Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global cell and tissue preservation market in 2030?
- What is the expected CAGR for the cell and tissue preservation market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global cell and tissue preservation market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell and Tissue Preservation Market
5.1. COVID-19 Landscape: Cell and Tissue Preservation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell and Tissue Preservation Market, By Type
8.1. Cell and Tissue Preservation Market, by Type, 2022-2030
8.1.1. Cell
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Tissue
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cell and Tissue Preservation Market, By Application Type
9.1. Cell and Tissue Preservation Market, by Application Type, 2022-2030
9.1.1. Therapeutics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Drug Discovery
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Gene therapy
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. IVF treatment
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Research & Development
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Cell therapy
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cell and Tissue Preservation Market, By Product Type
10.1. Cell and Tissue Preservation Market, by Product Type, 2022-2030
10.1.1. Equipment
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Software
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Bio-preservation Media
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cell and Tissue Preservation Market, By End User Type
11.1. Cell and Tissue Preservation Market, by End User Type, 2022-2030
11.1.1. Biobanks
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Cell and Tissue Preservation Market, By Cell Provider Type
12.1. Cell and Tissue Preservation Market, by Cell Provider, 2022-2030
12.1.1. CD34+
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. CD19+
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. MSC
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. iPSC
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. hESC
12.1.5.1. Market Revenue and Forecast (2017-2030)
12.1.6. Tumor Cells
12.1.6.1. Market Revenue and Forecast (2017-2030)
12.1.7. Others
12.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Cell and Tissue Preservation Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.7. Market Revenue and Forecast, by End User (2017-2030)
13.2.8. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.10. Market Revenue and Forecast, by End User (2017-2030)
13.2.11. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.13. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.15. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.9. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.9. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
Chapter 14. Company Profiles
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Lonza
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. BD
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. MerckKGaA
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cytiva
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Agilent Technologies, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Avantor, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. FUJIFILM Irvine Scientific
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. BioLifeSolutions Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. AMSBIO
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
14.11. Princeton CryoTech
14.11.1. Company Overview
14.11.2. Product Offerings
14.11.3. Financial Performance
14.11.4. Recent Initiatives
14.12. STEMCELL Technologies Inc.
14.12.1. Company Overview
14.12.2. Product Offerings
14.12.3. Financial Performance
14.12.4. Recent Initiatives
14.13. LGC SeraCare
14.13.1. Company Overview
14.13.2. Product Offerings
14.13.3. Financial Performance
14.13.4. Recent Initiatives
14.14. Corning Incorporated
14.14.1. Company Overview
14.14.2. Product Offerings
14.14.3. Financial Performance
14.14.4. Recent Initiatives
14.15. CellGenix GmbH
14.15.1. Company Overview
14.15.2. Product Offerings
14.15.3. Financial Performance
14.15.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1642
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments